Candriam Equities L Biotechnology C - Thesaurierung/  LU0108459040  /

Fonds
NAV13.05.2024 Diff.+5.8800 Ertragstyp Ausrichtung Fondsgesellschaft
826.0500USD +0.72% thesaurierend Aktien Candriam 
     
Chart for Candriam Equities L  Biotechnology C - Thesaurierung
  Titel   ISIN Performance Volatilität Sharpe Ratio
1. BIT Biotech Opportunities S DE000A3DCA95 +28.65% 32.25% 0.77
2. Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) SGD LU0320765992 +17.87% 17.79% 0.80
3. Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse Z (acc) GBP LU0774687577 +16.72% 18.07% 0.72
4. Abaris Biotech.Opportunities A EUR LU2210105669 +30.65% 37.89% 0.71
5. Abaris Biotech.Opportunities A CHF LU2210124454 +29.33% 38.59% 0.67
6. Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse I (acc) USD LU0195948822 +17.34% 18.87% 0.72
7. F.Biotechnology Dis.Fd.W USD LU0976566496 +17.30% 18.92% 0.72
8. F.Biotechnology Dis.Fd.Z USD LU1446800499 +16.98% 18.90% 0.70
9. Abaris Biotech.Opportunities A USD LU2210105313 +28.04% 39.67% 0.61
10. Biotech Core Mid-Cap Fund LI0237235184 +18.05% 22.95% 0.63
...
50. Candriam Equities L Biotechnology C - Thesaurierung LU0108459040 +4.16% 16.32% 0.02